Magnetic resonance radiomics for prediction of extraprostatic extension in non-favorable intermediate- and high-risk prostate cancer patients. (November 2020)

• Record Type: Journal Article
• Authors: Losnegård, Are; Reisæter, Lars A. R.; Halvorsen, Ole J.; Jurek, Jakub; Assmus, Jörg; Arnes, Jarle B.; Honoré, Alfred; Monssen, Jan A.; Andersen, Erling; Haldorsen, Ingfrid S.; Lundervold, Arvid; Beisland, Christian
• Is Part Of: Acta radiologica. Volume 61:Number 11(2020)
• Page Start: 1570
• Page End: 1579
• Publication Date: 2020-11
• Subjects: Prostate -- neoplasms primary -- magnetic resonance imaging -- computer applications – detection -- diagnosis; Radiology, Medical -- Periodicals; Radiography, Medical -- Periodicals; Radiotherapy -- Periodicals; 616.0757
• DOI: 10.1177/0284185120905066
• Languages: English
• ISSNs: 0284-1851

Abstract

Background: To investigate whether magnetic resonance (MR) radiomic features combined with machine learning may aid in predicting extraprostatic extension (EPE) in high- and non-favorable intermediate-risk patients with prostate cancer. Purpose: To investigate the diagnostic performance of radiomics to detect EPE. Material and Methods: MR radiomic features were extracted from 228 patients, of whom 86 were diagnosed with EPE, using prostate and lesion segmentations. Prediction models were built using Random Forest. Further, EPE was also predicted using a clinical nomogram and routine radiological interpretation and diagnostic performance was assessed for individual and combined models. Results: The MR radiomic model with features extracted from the manually delineated lesions performed best among the radiomic models with an area under the curve (AUC) of 0.74. Radiology interpretation yielded an AUC of 0.75 and the clinical nomogram (MSKCC) an AUC of 0.67. A combination of the three prediction models gave the highest AUC of 0.79. Conclusion: Radiomic analysis combined with radiology interpretation aid the MSKCC nomogram in predicting EPE in high- and non-favorable intermediate-risk patients.